These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26252737)

  • 1. Computational predictions of corroles as a class of Hsp90 inhibitors.
    Teo RD; Dong SS; Gross Z; Gray HB; Goddard WA
    Mol Biosyst; 2015 Nov; 11(11):2907-14. PubMed ID: 26252737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
    Shen G; Wang M; Welch TR; Blagg BS
    J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based and in silico design of Hsp90 inhibitors.
    Sgobba M; Rastelli G
    ChemMedChem; 2009 Sep; 4(9):1399-409. PubMed ID: 19685544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
    Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
    J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
    Li Z; Jia L; Wang J; Wu X; Hao H; Wu Y; Xu H; Wang Z; Shi G; Lu C; Shen Y
    Eur J Med Chem; 2014 Nov; 87():346-63. PubMed ID: 25277067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning from nature: advances in geldanamycin- and radicicol-based inhibitors of Hsp90.
    Kitson RR; Moody CJ
    J Org Chem; 2013 Jun; 78(11):5117-41. PubMed ID: 23496136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrating for resistance to radicicol.
    Duerfeldt AS; Blagg BS
    ACS Chem Biol; 2009 Apr; 4(4):245-7. PubMed ID: 19371133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?
    Khandelwal A; Crowley VM; Blagg BSJ
    Med Res Rev; 2016 Jan; 36(1):92-118. PubMed ID: 26010985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the chaperone kinome pathway: mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    Biochem Biophys Res Commun; 2011 Jan; 404(1):498-503. PubMed ID: 21144839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on the microbes that produce heat shock protein 90-targeting antibiotics.
    Piper PW; Millson SH
    Open Biol; 2012 Dec; 2(12):120138. PubMed ID: 23271830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site.
    Hadden MK; Lubbers DJ; Blagg BS
    Curr Top Med Chem; 2006; 6(11):1173-82. PubMed ID: 16842154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition and function of heat shock proteins 70 and 90.
    Blagg BS
    Curr Top Med Chem; 2009; 9(15):1335-6. PubMed ID: 19925436
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors.
    Zhang MQ; Gaisser S; Nur-E-Alam M; Sheehan LS; Vousden WA; Gaitatzis N; Peck G; Coates NJ; Moss SJ; Radzom M; Foster TA; Sheridan RM; Gregory MA; Roe SM; Prodromou C; Pearl L; Boyd SM; Wilkinson B; Martin CJ
    J Med Chem; 2008 Sep; 51(18):5494-7. PubMed ID: 18800759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in the study of heat shock protein 90 inhibitors].
    Luo HM; Sun W; Yin JY; Yang XH
    Yao Xue Xue Bao; 2010 Jul; 45(7):813-20. PubMed ID: 20931776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.
    Li L; Wang L; You QD; Xu XL
    J Med Chem; 2020 Mar; 63(5):1798-1822. PubMed ID: 31663736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes.
    Wang Y; McAlpine SR
    Chem Commun (Camb); 2015 Jan; 51(8):1410-3. PubMed ID: 25333923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90.
    Palma LC; Ferreira LFGR; Petersen ALOA; Dias BRS; Menezes JPB; Moreira DRM; Hernandes MZ; Veras PST
    Sci Rep; 2019 Oct; 9(1):14756. PubMed ID: 31611575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hsp90 inhibitor radicicol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ.
    Guarnieri MT; Zhang L; Shen J; Zhao R
    J Mol Biol; 2008 May; 379(1):82-93. PubMed ID: 18440021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and In Vitro Investigation of Novel Basic Celastrol Carboxamides as Bio-Inspired Leishmanicidal Agents Endowed with Inhibitory Activity against
    Bassanini I; Parapini S; Ferrandi EE; Gabriele E; Basilico N; Taramelli D; Sparatore A
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33466300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining the Phenotype of Heat Shock Protein 90 (Hsp90) Inhibitors.
    Wang Y; Koay YC; McAlpine SR
    Chemistry; 2017 Feb; 23(9):2010-2013. PubMed ID: 27862436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.